PDE4A and asthma: Reports of a role for PDE4 inhibitors in asthma and COPD treatment [14] together with the known interactions between the MAPK and cAMP pathways [16,17] lead to our interest for possible nicotine-induced changes in PDE4 and cAMP pathway.